377 filings
Page 12 of 19
6-K
330uzx mv43fke
13 Feb 17
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt
12:00am
6-K
nvwp0t1a
7 Feb 17
GW Pharmaceuticals plc Reports First Quarter 2017 Financial Results and Operational
12:00am
6-K
njpdwea22wbqllrgbh1
9 Jan 17
Current report (foreign)
12:00am
CT ORDER
ddea6yw0x
22 Dec 16
Confidential treatment order
12:00am
6-K
y0bpcux6hq2
20 Dec 16
Current report (foreign)
12:00am
6-K
qahfu
5 Dec 16
GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2016 Financial Results and Operational Progress
12:00am
6-K
4dex5hp8t5rga
3 Nov 16
Current report (foreign)
12:00am
6-K
p1taak n2u
26 Oct 16
Current report (foreign)
12:00am
6-K
1btkebam
19 Oct 16
GW Pharmaceuticals plc Announces Intention to Continue Trading Exclusively on NASDAQ and Planned Cancellation of Trading of Ordinary Shares on AIM
12:00am
6-K
okmw8v11fl cimgpfzvq
7 Oct 16
Current report (foreign)
12:00am
6-K
f94qxlx25po608lbi2
26 Sep 16
GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for Epidiolex® (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome
12:00am
6-K
j8b aj3r5fjlyl3lis
14 Sep 16
Current report (foreign)
12:00am
6-K
m8v9d
9 Aug 16
GW Pharmaceuticals plc Reports Third Quarter 2016 Financial Results and Operational Progress
12:00am
6-K
ftw hrz9r377b4yp
18 Jul 16
Current report (foreign)
12:00am
424B5
ehxiry7c
14 Jul 16
Prospectus supplement for primary offering
12:00am
6-K
7uyay5hn5gwu2by3
14 Jul 16
Current report (foreign)
12:00am
FWP
spm5w45zd 2y0i0hd
13 Jul 16
Free writing prospectus
12:00am
6-K
ff3209w
12 Jul 16
Current report (foreign)
12:00am
424B5
mvawe9qolo7czv o6
12 Jul 16
Prospectus supplement for primary offering
12:00am